
Finding Lung Cancer Before It’s Too Late: From Uncertainty to Action
In this episode of Diagnosing Dx, I’m joined by Maria Zannes, Chief Executive Officer and Director at bioAffinity Technologies. Maria shares her journey from journalism and business leadership into diagnostics, and explains how bioAffinity Technologies is building a non-invasive platform for lung disease diagnosis, starting with early lung cancer detection. We explore the limitations of current pathways for indeterminate pulmonary nodules, how CyPath Lung is designed to support faster, more confident decision-making, and why earlier detection can have such a major impact on outcomes. We also discuss what it really takes to build and scale in diagnostics, from clinical validation and workflow adoption to balancing commercialization with continued innovation. From lung cancer screening and clinical trials to asthma, COPD, and future opportunities in the platform, this is a practical conversation about bringing meaningful diagnostic advances to market.
Publisher
Diagnosing Dx
Link
podcasters.spotify.com/pod/show/medtech-disruptors2/episodes/Finding-Lung-Cancer-Before-Its-Too-Late-From-Uncertainty-to-Action-e3h81o3
Published
March 31, 2026
Duration
43 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Elevra Consulting
Diagnosing Dx
@diagnosingdx
#findinglungcancer #toolate #uncertainty #lifesciences
